Mediators of Inflammation

Volume 2014 (2014), Article ID 476357, 14 pages

http://dx.doi.org/10.1155/2014/476357

Review Article

Importins and Exportins Regulating Allergic Immune Responses

Ankita Aggarwal and Devendra K. Agrawal

Department of Medical Microbiology & Immunology and Center for Clinical & Translational Science, Creighton University School of Medicine, Omaha, NE 68178, USA

Received 9 December 2013; Revised 18 January 2014; Accepted 21 January 2014; Published 9 March 2014

Academic Editor: Peisong Gao

Copyright © 2014 Ankita Aggarwal and Devendra K. Agrawal. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Nucleocytoplasmic shuttling of macromolecules is a well-controlled process involving importins and exportins. These karyopherins recognize and bind to receptor-mediated intracellular signals through specific signal sequences that are present on cargo proteins and transport into and out of the nucleus through nuclear pore complexes. Nuclear localization signals (NLS) present on cargo molecules to be imported while nuclear export signals (NES) on the molecules to be exported are recognized by importins and exportins, respectively. The classical NLS are found on many transcription factors and molecules that are involved in the pathogenesis of allergic diseases. In addition, several immune modulators, including corticosteroids and vitamin D, elicit their cellular responses by regulating the expression and activity of importin molecules. In this review article, we provide a comprehensive list of importin and exportin molecules and their specific cargo that shuttled between cytoplasm and the nucleus. We also critically review the role and regulation of specific importin and exportin involved in the transport of activated transcription factors in allergic diseases, the underlying molecular mechanisms, and the potential target sites for developing better therapeutic approaches.

1. Introduction

The trafficking of molecules between the cytoplasm and the nucleus in eukaryotes is regulated by nuclear pore complexes (NPCs or nucleoporins), which are cylindrical structures containing about 100 different polypeptides and embedded in the double membrane of the nuclear envelope. The regulation of bidirectional movement of molecules within a cell is critical in the exchange of molecules in and out of the nucleus and precise control of signal transduction processes as well as gene expression, cell cycle progression, and other cellular responses. Generally, the molecules up to 38–50 kDa in size may passively diffuse through the nuclear pore complexes. However, molecules larger than 50 kDa require machinery whereby mobile targeting receptors called karyopherins recognize and bind to receptor-mediated intracellular signals through specific signal sequences that are present on substrate proteins. Depending upon the movement of macromolecules from cytoplasm to nucleus or nucleus to cytoplasm, these karyopherins target the substrates that contain nuclear localization signal (NLS) or nuclear export signals (NES). The classical amino acid sequence in the NLS is PKKKRRV that mediates the nuclear translocation of large molecules from the cytoplasm [1]. The nuclear export signals (NES) typically contain the sequence LQLPPLERLTL, which directs the proteins to leave the nucleus [2].

The first conventional NLS is recognized by an adaptor protein, importin-α (also known as karyopherin-α), that functions as the NLS receptor. The importin-α interacts with importin β (also known as karyopherin-β), which mediates the process of docking to the nucleoporins. The protein containing NLS is transported through NPC to the nucleus by importin α/β heterodimeric complex. This translocation of the substrate-receptor complex through the NPC requires energy provided by a low molecular weight Ras-family GTPase, Ran, which is present in the nucleus. After translocation to the nucleus, the importin heterodimeric complex dissociates by the action of Ran-GTP, whereby the importin-α and the substrate enter and accumulate in the nucleoplasm while importin-β binds to Ran-GTP and accumulates at the NPC [2]. Thus, the import of protein substrates bound to NLS receptors in the cytoplasm does not require Ran-GTP. However, the release of the protein substrate in the nucleus is dependent upon Ran-GTP binding to the complex. Finally, importin α/β returns back to the cytoplasm to import additional protein molecules into the nucleus (Figure 1).

Figure 1: Nucleocytoplasmic transport of macromolecules via importin-exportin pathway. In the cytoplasm, importin-α forms a heterotrimeric complex with importin-β1, RanGDP, and NLS containing cargo protein. This heterotrimeric complex passes through the NPC into the nucleus and RanGTP binds to importin-β1 and disassembles the complex in the nucleus. The binding of exportin to NES within the cargo protein is triggered by RanGTP in the nucleus and is exported back to the cytoplasm through nuclear pore complex (NPC). In the cytoplasm, the dissociation of the complex is mediated through the hydrolysis of RanGTP to RanGDP by GAP (GTPase activating protein) that forces the binding of GDP to Ran. GEF (guanine nucleotide exchange factor) is a nucleoplasmic factor that stimulates exchange of GDP with GTP forming RanGTP in the nucleus.

Nuclear export of proteins occurs through NES in an analogous manner by exportins, which are homologous to importin-β. However, this requires the binding of Ran-GTP to protein-NES-exportin complex. After the cytoplasm has been reached, the hydrolysis of RanGTP to RanGDP by Ran GTPase-activating protein occurs, resulting in the dissociation of the complex of exportin and protein. The direction in which protein is carried is generally determined by the gradient of Ran GTPase because the majority of RanGDP and Ran-GTPase-activating proteins are found in the cytoplasm, whereas Ran-GTP and Ran-guanine nucleotide exchange factors (Ran-GEF) are primarily present in the nucleus [3].

Human importins and exportins are classified into four subfamilies. First family is importin αP that consists of importin α1 [4], second family is importin αQ, including importins α3 and α4 [5], third family is importin αS including importins α5, α6, and α7 [5–7], and the fourth family is importin β that consists of importins β1, β2, and β3, importins 7, 8, and 12, exportins 1, 5, and 6, and exportin t [8]. However, there are few human importin/exportin molecules that have not been yet categorized into a subfamily. These are importins 4, 9, 11, and 13, transportin 2, and exportins 4 and 7. Different subfamily members share around 50% sequence identity. The similarity in sequence within a subfamily is around 85%. Despite of these subtle differences in the sequence, they possess similar pattern of recognition of NLS on cargo proteins. However the experimental evidence is provided by many studies validating the fact that different importin/exportin molecules possess distinct properties in terms of interacting with the NLS of specific cargo proteins [6, 9, 10]. A comprehensive summary of human importins and exportins along with their alternative names, short names, and the gene symbols given by NCBI (National Center for Biotechnology Information) is provided in Table 1. There also are nonconventional nuclear transport mechanisms that are distinct from the classical concept of importing proteins which are responsible for the import of molecules into the nucleus by directly binding to specific importin β1 homologs from importin β family.

Table 1: Names and symbols of human importins and exportins.

Transporters
Alternative name/s
Short name/s
NCBI symbols

Importin α1/

Importin α2
Karyopherin α2

RAG cohort protein 1

SRP1-α
RCH1

SRP1
KPNA2

Importin α3
Importin α Q1

Karyopherin α4
Qip1
KPNA4

Importin α4
Importin α Q2

Karyopherin α3
Qip2

SRP-1γ
KPNA3

Importin α5
Karyopherin α1

Nucleoprotein interactor 1

RAG cohort protein 2
NPI-1

SRP1-β

RCH2
KPNA1

Importin α6
Karyopherin α5
—
KPNA5

Importin α7
Karyopherin α6
IPOA7
KPNA6

Importin β1
Importin 90

Karyopherin β1

Nuclear factor p97

Pore targeting complex 97 kDa subunit
PTAC97

NTF97
KPNB1

Importin β2
Transportin 1

Karyopherin β2

M9 region interaction protein
KPNB2

MIP1

TRN
TNPO1

Importin β3
Importin 5

Karyopherin β3

Ran-binding protein 5
Imp5

KPNB3

RanBP5
IPO5

Importin 4
Importin 4b

Ran-binding protein 4
Imp4b

RanBP4

IMP4B
IPO4

Importin 7
Ran-binding protein 7
Imp7

RanBP7
IPO7

Importin 8
Ran-binding protein 8
Imp8

RanBP8
IPO8

Importin 9
Ran-binding protein 9
Imp9

RanBP9

KIAA1192

HSPC273
IPO9

Importin 11
Ran-binding protein 11
Imp11

RanBP11
IPO11

Importin 12
Transportin 3

Transportin-SR
Imp12

TRN-SR

IPO12
TNPO3

Importin 13
Karyopherin 13
Kap13

RanBP13

KIAA0724
IPO13

Transportin 2
Karyopherin β2b
—
TNPO2

Exportin 1
Chromosome region maintenance 1 protein homolog
Exp1

CRM1
XPO1

Exportin 4
—
Exp4

KIAA1721
XPO4

Exportin 5
Ran-binding protein 21
Exp5

KIAA1291

RanBP21
XPO5

Exportin 6
Ran-binding protein 20
Exp6

KIAA0370

RanBP20
XPO6

Exportin 7
Ran-binding protein 16
Exp7

KIAA0745

RanBP16
XPO7

Exportin t
tRNA exportin
—
XPOT

Karyopherins recognize various cargo molecules and bind to them by interacting with NLS or NES present on cargo molecules. However, the specificity of importins or exportins for each cargo would depend upon the structure and direct interaction of importin-cargo molecules. In Table 2, a summary of cargos that bind directly to importins and exportins is provided.

Table 2: Specificity of different classes of importins/exportins in transporting cargo to and from the nucleus.

Transporters
Organism
Cells/Tissue
Cargo (proteins) specific to each importin or exportin
Reference

Importin α1
Human
ROS 17/2.8, UMR-106, MC3T3-E1, and SaOS-2
Type 1 parathyroid hormone receptor
[62]

Importin α2
Human
HuT-78 cells
GATA-3
[63]

Importin α3
Human
A5A9 lung cells, human Bronchial smooth muscle cells
NF-κB p50/p65
[25, 50]

Importin α3
Mouse
Mouse lung tissue
NF-κB p65
[11]

Importin α4
Human
A5A9 lung cells
NF-κB p50/p65
[25]

Importin α5
Human
COS-1

HepG2

HuH7 hepatoma cells
STAT3

STAT1-STAT2
[45]

[43]

Importin β1
Human
HEK293

HUVEC

C58

CO57

HeLa
PRPF31

NF-κB

CREB

PTHrP

SRY/SOX-9

Cyclin B1

NFAT
[64–69]

[33]

[68]

Importin β1
Mouse
Sf9
NFAT
[69]

Importin β2
Human
HeLa
HPV16E6 oncoprotein
[70]

Importin β3
Human
HeLa
c-Jun

Ribosomal proteins
[71, 72]

Importin 4
Human
HeLa
Vitamin D receptor

HIF1-α
[73, 74]

Importin 5
Human
HeLa
c-Jun
[70]

Importin 7
Human
HeLa
c-Jun

Histone H1

CREB

SMAD3

Glucocorticoid receptor
[71]

[75, 76]

[33]

[48]

[55]

Importin 8
Human
HaCaT

COS-1
SMADs

Signal recognition particle protein 19
[76, 77]

Importin 9
Human
HeLa
c-Jun

PP2A (PR65)
[71]

[78]

Importin 11
Human
BHK
L12

UbcM2
[79, 80]

Importin 13
Human
HeLa

Airway epithelial cells
c-Jun

Glucocorticoid receptor
[71] [57]

Importin α/β
Human
HTC

MCF-7
HIV-1 integrase

P53
[81, 82]

Exportin 1
Human
NIH-3H3

HeLa
Cyclin D1

IκB

NFAT
[14, 26, 83, 84]

Exportin 4
Mouse
HeLa
elF-5A
[15]

Exportin 5
Human
BHK
Staufen2
[85]

Exportin 6
Human

Actin
[86]

Exportin 7
Human
HeLa

BHK
P50RhoGAP
[87]

Exportin t
Human
HeLa
tRNA
[72, 88]

2. Molecules Involved in Allergic Immune Response

Inflammation is a hallmark of allergic diseases, including asthma, allergic rhinitis, and atopic dermatitis. In most of the allergic diseases, inflammation is primarily characterized by the predominance of Th2 lymphocytes and the specific cellular response of Th2 cytokines, IL-4, IL-5, IL-9, and IL-13. IL-4 mediates the class switching of IgM secreted by plasma cells to allergen specific IgE, IL-5 is a major cytokine involved in eosinophilic inflammation, and IL-13 is partly involved in class-switching event and plays a key role in goblet cell hyperplasia and mucus production [11]. IL-9 was initially described as a growth factor for T-lymphocyte and mast cells and is released from many cell types, including Th2 cells, eosinophils, mast cells, and neutrophils. IL-9 can induce multiple effects in the initiation, exacerbation, and maintenance of allergic airway inflammation and airway remodeling (Figure 2).

Figure 2: Schematic diagram showing the involvement of transcriptional factors in response to key mediators of allergic inflammation: binding of Th2 cytokines to their specific receptors and the activation of the downstream JAK/STAT pathways specific to each cytokine are shown. JAK: Janus activated kinase; NPC: nuclear pore complex; STAT: signal transducer and activator of transcription; TyK2: tyrosine kinase 2.

Patients with allergic respiratory diseases have a biased immune response towards Th2 phenotype, contrasting that of healthy individuals in which the host-defense mechanisms maintain a balance between Th1 and Th2 phenotypes. The differentiation of Th2 cells is regulated by zinc finger transcriptional factor GATA-3, suggesting a key role of GATA-3 in mediating allergic immune response [12]. There is a pivotal role of bronchial smooth muscle cells in the pathogenesis of airway inflammation [13]. The increase in bronchial smooth muscle mass narrows the airway lumen, which further obstructs the airflow. There are a number of inflammatory cytokines secreted by bronchial smooth muscles such as TNF-α, IL-6, IL-17, IL-8, and IL-1β. Indeed, nearly every structural cell in the lung, including epithelial cells and infiltrated cells, becomes activated during allergic immune response. Thus, airway inflammation, due to the effect of various cytokines and mediators released by the cells in the lung, is a hallmark of allergic diseases.

The transcription, translation, and release of cytokines during allergic response depend upon specific signals, activation of intracellular kinases, and transcription factors present in the cytoplasm (Figure 2). STAT6 is vital to inducing the expression of Th2 cytokines, initiating allergic immune responses in many allergic diseases [14, 15]. The activated NF-κB is one of the transcriptional factors that trigger airway hyperresponsiveness and allergic airway inflammation by rapidly inducing the expression of various genes involved in the pathology of allergic diseases [16]. However along with AP-1, it can further enhance the production of proinflammatory cytokines such as IL-1 and TNF-α [17]. Th17 cells are another subset of T helper cells that are differentiated from naïve T cells in the presence of TGF-β, and a very potent inflammatory cytokine, IL-6, is credited with inducing pathology in allergic inflammatory diseases [18]. RORγt is a transcriptional factor responsible for the differentiation of Th17 cells via signal transducer and activator of the transcription 3 (STAT3)-RORγt pathway. The activation and functionality of transcriptional factors determine the fate of T cell differentiation and the cytokine secretion according to the lineage of the T cell. Th1 cells express Th1 master regulator, T-box transcriptional factor (T-bet), which is induced via STAT4 or STAT1 signaling pathways [19]. Runx3 is another transcriptional factor whose expression is upregulated by Th1 cells. If the conditions favoring the differentiation of Th1 cells are present, then the differentiation of Th2 cells will be inhibited. IL-4 encoding genes are silenced by T-bet and Runx3 [20], suggesting that targeting IL-4 signaling is one of the therapeutic approaches to attenuating allergic airway inflammation. On the other hand, Th2 cell differentiation is accompanied by IL-4 through STAT6, which in turn induces GATA-3 the master regulator for Th2 cell differentiation [21].

The activation of the respective transcriptional factors is a key component to the induction or alleviation of allergic inflammation. The transcriptional factors responsible for inducing or reducing allergic inflammation must enter the nucleus of the target cell and bind to their specific response elements to exhibit their functional role. Small molecules up to ~40 kDa can easily diffuse through the nuclear pore complexes, whereas the larger molecules require help from import and export molecules to get through the nuclear membrane. The import-export machinery responsible for such translocation consists of importins and exportins. In the following section, the role of specific importin or exportin molecules in the transport of specific transcription factors involved in allergic inflammation will be discussed.

3. Effect of Importins/Exportins on Key Transcription Factors Involved in Allergic Inflammation Rel or NF-κB

Since importins and exportins play a crucial role in transporting macromolecules into and out of the nucleus, their regulation is critical in cellular responses (Figure 3). Rel/NF-κB p50/p65 is actively involved in cell differentiation, host immune response and in the transcription of many inflammatory cytokines [22]. Rel/NF-κB activation is critical for the induction and stimulation of allergic airway inflammation. Indeed, increased activation of activated Rel/NF-κB has been found in immune cells and structural cells of the lungs in asthmatic subjects [23, 24]. TNF-α, IL-17, and IL-1β are crucial proinflammatory cytokines that are secreted by many cells in the airway during allergic airway inflammation and activate NF-κB [24]. In the latent state, Rel/NF-κB remains in the inactive state complexed with IκB-IKK complex in the cytosol. IKK complex consists of three distinct subunits: IKKα and IKKβ as catalytic subunits and IKKγ (also called as NEMO) as a regulatory subunit to sense scaffold and to integrate the upstream signals to activate catalytic subunits. Once signaled, IKK complex is activated, leading to phosphorylation of IKKβ. This results in the ubiquitination of IκBα followed by degradation by the 26S proteasome. This releases the Rel/NF-κB dimers containing primarily p50–p65 subunits to enter the nucleus and activate target gene expression. Due to the large size of Rel/NF-κB dimers, the translocation event is triggered by importins (Figure 3). NF-κB subunits p50 and RelA contain classical nuclear localization signals that are unmasked after ubiquitination and degradation of IκBα prior to their translocation to the nucleus by importin α/β heterodimer [25].

Figure 3: Binding of specific importin molecules to transcription factors: the figure shows the recognition of nuclear localization signal (NLS) by specific importin (Imp) molecules on activated transcriptional factors in the cytoplasm, binding of importin β, and transport of the cargo to the nucleus through nuclear pore complex (NPC).

Fagerlund and colleagues have presented strong evidence in their study to suggest that importins α3 and α4 are responsible for the translocation of TNF-α-stimulated active subunits of NF-κB to the nucleus from the cytoplasm [25] and the subsequent export back into the cytoplasm with the support of exportin, CRM1 (chromosome region maintenance 1) [26, 27]. This exportin has sequence similarity with karyopherin β1 and interacts with nucleoporin Nup214 and exports NF-κB to the cytoplasm, thereby inhibiting its accumulation in the nucleus. Thus, importin α3 and importin α4 together with CRM1 are critical karyopherins involved in the import and export of NF-κB in nucleocytoplasmic translocation during allergic airway inflammation (Figure 3).

Recently, several molecules have been identified which might have a significant effect on CRM1-dependent export of NF-κB and retention of NF-κB in the nucleus. These molecules include prohibitin [11, 27, 28], HSCARG [29], poly(ADP-ribose)polymerase-1 [30], and heat shock protein 72 (Hsp72) [31]. However, the potential presence of additional endogenous mediators as a natural defense mechanism in response to NF-κB activity cannot be ruled out. The underlying mechanisms by which these molecules influence import nucleocytoplasmic shuttling of NF-κB are unclear and warrant further investigation. Nonetheless, there is a potential to develop novel therapeutics in controlling allergic inflammation and the treatment of allergic diseases due to increased activity of NF-κB.

4. AP-1

Activator protein-1 (AP-1) is another transcriptional factor that plays a crucial role in the induction of cellular differentiation, gene expression, and apoptosis. Active AP-1 enhances the secretion of proinflammatory cytokines, including TNF-α and IL-1. In response to allergic inflammatory mediators, both AP-1 and NF-κB are activated and these transcription factors can synergistically induce the transcription and generation of inflammatory mediators to induce allergic and autoimmune diseases. AP-1 consists primarily of two components, c-jun and c-fos, and the active AP-1 is made up of homodimer or heterodimer of these subunits [32]. The homodimer or heterodimer of activated AP-1 enters into the nucleus primarily through importin β1 that recognizes subunits of AP-1 in importin-α-independent manner (Figure 3). In fact, Importin β1 binds to AP-1 subunits, jun and fos, with higher affinity than that of importin-α [33]. Thus, by controlling the binding of importin β1, the nuclear translocation of AP-1 may be regulated and could thus be useful in the attenuation of inflammation in allergic diseases.

There are no reports in human cells in regard to the export of AP-1. However, in yeast it has been found that β-karyopherin-like nuclear exporter, Crm1p, recognizes and binds to the nuclear export sequence on AP-1 in the presence of RanGTP, and this process is inhibited by oxidation [34].

5. GATA-3

GATA-3 is a transcriptional factor that mediates the differentiation and proliferation of Th2 cells [35]. Th2 cytokines, IL-4, IL-5, IL-9, and IL-13, are predominantly regulated by GATA-3 and critically involved in the pathogenesis of allergic airway inflammation. IL-4 and IL-13 are mainly responsible for inducing antigen specific IgE while IL-5 is involved in eosinophilic inflammation. GATA-3 plays a pivotal role in mediating allergic diseases, such as allergic rhinitis, asthma, and atopic dermatitis, and therefore is a key target in developing better therapeutic approaches. Indeed, the knockdown of GATA-3 under both in vivo and in vitro conditions reduces Th2 cytokines, resulting in inhibited allergic inflammation [36, 37]. GATA-3 contains a classical nuclear import signal that is recognized by importin α and thus translocates to the nucleus [37]. The deletion of the region, which is critical for the interaction of the NLS in AP-1 and importin α, hinders nuclear translocation of activated AP-1 [38]. The p38 MAPK-mediated serine phosphorylation on GATA-3 is critical for nuclear import of GATA-3 from cytoplasm after its interaction with importin α [37]. Upon arrival in the nucleus, GATA-3 binds to its response element in the promoter region of Th2 cytokines, increases their gene expression, thus stimulates IgE class switching by increased production of IL-4 and IL-13, and induces eosinophilic inflammation (Figure 3).

An endogenous inhibitor, MAPK phosphatase-1 (MKP-1), inhibits the phosphorylation and activation of p38 MAPK [37]. The inhibition of p38-MAPK leads to the downregulation of Th2 cytokines [39]. The interaction between importin α and NLS on GATA-3 is affected due to the inhibition of p38 MAPK, resulting in the attenuation of nuclear translocation of GATA-3 from cytoplasm (Figure 3). This, in turn, leads to the downregulation of Th2 cytokines and reduced allergic airway inflammation. The results from animal studies also support the fact that the inhibition of the phosphorylation of p38 MAPK causes a reduction in allergic airway inflammation. This is further supported by findings in which the suppressed activity of p38 MAPK reduced eosinophilic inflammation in mice and guinea pigs that were exposed to OVA [40]. Mice sensitized and challenged with OVA were aerosolized with the SB239063, a potent inhibitor of p38 MAPK inhibitor, showed reduced eosinophilic inflammation, and attenuated airway hyperresponsiveness and mucus production, and there was downregulation in IL-4, IL-5, and IL-13 in the bronchoalveolar lavage fluid. These findings suggest that GATA-3 is regulated via its nuclear import gene importin α. Thus, potential inhibitors of importin α binding to the NLS on GATA-3 could be therapeutically useful in regulating allergic inflammation.

There is no data available at this time on the export of GATA-3 from nucleus to cytoplasm. However, the potential role of CRM-1 cannot be ruled out.

6. STAT6, STAT1, and STAT2

Th2 cytokines, IL-4 or IL-13, activate signal transducer and activator of transcription (STAT) 6 by binding to their receptor IL-4Rα that mediates JAK1 and JAK3, and further activates STAT6 classical pathway. The critical role of STAT6 on IgE class switching, Th2 differentiation, and IL-4 mediated responses is supported by the fact that such effects are drastically impaired in STAT6 knockout mice [41]. STAT6, upon tyrosine phosphorylation, becomes active and translocates to the nucleus by importin α-importin β1 receptors (Figure 3). STAT6 also possesses the binding sites for importins α3 and α6 [42]. Little is known about the STAT6 complex crystal structure; however, the data available in the literature suggests that it can be regulated by targeting the importins responsible for its translocation into the nucleus. This suggests an important role of inhibiting or downregulating importins to alleviate allergic diseases.

Both STAT1 and STAT2 are activated in response to type I interferons, IFN-α, IFN-β, and IFN-ω. Both STAT1 and STAT2 have an arginine/lysine-rich nuclear localization signal. The tyrosine-phosphorylation on Tyr-701 and Tyr-69 on STAT1 and STAT2, respectively, results in the dimerization of STAT1-STAT2, and this heterodimer translocates to the nucleus. The NLS on STAT1-STAT2 heterodimer is recognized by and binds to two importin α5 molecules that are responsible for their translocation into the nucleus (Figure 3) [43].

7. STAT3, RORγt, and Smad3

IL-6, a proinflammatory cytokine responsible for differentiating Th0 cells into pathogenic Th17 cells, activates STAT3 transcription factor. STAT3 is also responsible for the Th17 cell differentiation. It binds to importin α3 and importin α6 and is actively transported into the nucleus with the help of these karyopherins [44]. It has also been shown that nuclear import of STAT3 occurs independent of tyrosine phosphorylation. According to another study, it has been shown to have binding sites for importin α5 and importin α7 as well; however, importin α7 has weak interactions with STAT3 [45] (Figure 3).

IL-6 and TGF-β contribute to induce the expression of RORγt (transcriptional factor, required for the initiation and survival of Th17 cell). Other than our knowledge of its involvement in mediating allergic immune diseases, there is no information on its nuclear versus cytoplasmic movement. However, there is no karyopherin-recognizable nuclear localization sequence present on RORγt [46, 47]. Hence, the translocation of RORγt from the cytoplasm into the nucleus is carried by S6K2, a nuclear counterpart of S6K1, which is induced by PI3 K-Akt-mTORC1 axis [47]. The S6K2 possess functional classical NLS at its C-terminus. It binds to RORγt and then carries it into the nucleus from cytoplasm. Since PI3 K-Akt-mTORC1 axis suppresses Gfi1 expression to positively regulate Th17 differentiation and enhances the S6K2 expression responsible for nuclear translocation of RORγt, the PI3K-Akt-mTORC1 axis-S6K2 is a novel target to limit the differentiation of pathogenic Th17 cell differentiation and could thus be a useful therapeutic approach to control allergic inflammation.

Smad3 is activated in response to TGF-β, which is not only a key factor involved in the expression of RORγt and differentiation of Th17 cells, but also critical in the resolution phase of inflammation by induction of fibrosis at the site allergic reactions. Both importin β and importin 7 are utilized in the transport of activated Smad3 from cytoplasm to nucleus [48, 49] (Figure 3).

8. Allergic Immune Regulation by Importins and Exportins

Recently, we found that vitamin D decreases airway hyperresponsiveness and allergic airway inflammation via its receptor VDR (vitamin D receptor) that acts to downregulate importin α3 in ovalbumin-sensitized and -challenged mice [11]. Although there are several mechanisms proposed in the literature on the beneficial effect of vitamin D in alleviating allergic immune responses, one of the potential targets is importins [50]. Calcitriol, an activated form of vitamin D, stimulates VDR and exerts its beneficial effect by suppressing cell growth, cell proliferation and cell differentiation, and immune regulation. VDR interacts with its response elements in the nucleus and alters the transcription of the subsequent target genes involved in the biological response. We also found that vitamin D reduces allergic responses by increasing the protein expression of prohibitin, a molecule that regulates the activity of importins and its binding to inflammatory transcription factors [51].

Prohibitin (PHB) is a protein that is expressed ubiquitously in cell and mitochondrial membranes and in the nucleus. It is a multifunctional protein that is implicated in various regulatory functions such as proliferation, differentiation, apoptosis, transcription, and protein folding [52]. The expression of PHB decreases in the tissues under inflammatory conditions, including inflammatory bowel disease and airway inflammation, suggesting its potential role as an anti-inflammatory gene [53]. Overexpression and/or restoration of PHB in intestinal epithelial cells downregulated importin α3, an importin involved in NF-κB nuclear translocation [27]. Recently, under both in vitro and in vivo conditions, we found the downregulation of importin α3 at both the mRNA and protein levels by prohibitin in response to the activation of calcitriol-activated VDR [11, 34]. In vitamin D-deficient allergic asthmatic mice there was a significant reduction in prohibitin due to an upregulation of importin α3 and thus increased translocation of activated NF-κB from the cytoplasm into the nucleus. In vitamin D-sufficient and vitamin D-supplemented mice, the VDR compartments remain intact to keep sufficient amount of prohibitin levels for controlling cellular activity. This regulates importin α3-mediated nuclear translocation of NF-κB and thus reduces allergic airway inflammation and airway hyperresponsiveness in response to allergen challenge in allergen-sensitized mice [11]. Thus, in inflammatory conditions, a decrease in expression of either or both VDR and PHB leads to an increase in importin α3 expression and its activity, resulting in the exaggeration of allergic inflammatory response.

Corticosteroids are potent anti-inflammatory agents and regulate the activity of several transcriptional factors involved in allergic inflammation [54]. Although there could be several potential mechanisms for the underlying anti-inflammatory effects of corticosteroids, one of the major effects is the inhibition of nuclear translocation of activated transcription factors, including GATA-3 and NF-κB (Figure 4). Corticosteroids are highly efficient in suppressing Th2 cytokines in the airways of individuals with allergic asthma. The anti-inflammatory effect by corticosteroids is exerted via binding to cytosolic glucocorticoid receptors (GR). After interacting with their receptors, corticosteroid-GR complex translocates to the nucleus from the cytoplasm where they bind to the promoter region of steroid-sensitive genes containing glucocorticoid response elements (GREs). The activated glucocorticoid receptors suppress inflammatory action exerted by NF-κB via interaction with coactivator molecules. This is achieved by inhibiting either the nuclear translocation of NF-κB by upregulating endogenous regulatory molecules, including prohibitin, or by inducing more inhibitory subunits, IκB, of NF-κB, to keep them inactive in the cytoplasm (Figure 4).

Figure 4: Activation of glucocorticoid receptor (GR) and control of allergic inflammation:corticosteroids are lipophilic in nature and cross the bilipid membrane to bind to their receptors in the cytoplasm. The nuclear localization signal (NLS) on steroid-receptor complex can be recognized by importin α, importin 7, or importin 13 to transport the steroid-receptor complex to the nucleus to bind to glucocorticoid-response element (GRE) to induce the transcription of several genes that elicit anti-inflammatory effect. Also, the steroid-receptor complex in the cytoplasm can also induce effects on the nuclear transport of activated transcription factors by either inhibiting the binding of activated transcription factors to importins or increasing the inhibitory molecules, such as prohibitin, in the cytoplasm.

The major event to exert anti-inflammatory effect is mediated via the nuclear translocation of corticosteroid-GR complex. The nuclear translocation signals responsible for nuclear transport and retention of activated GR are NL1 and NL2, where NL1 is similar in sequence to Simian virus 40 and the NL2 of GR is poorly defined [55, 56]. These nuclear localization signals are present on importins (Figure 4). Additionally, their nuclear export is mediated by chromosomal region maintenance (CRM-1) pathway.

Several importins have been found to be involved in the nuclear translocation of corticosteroid-GR complex. NL1 of GR binds to importin α and is responsible for importing corticosteroids into the nucleus. In addition, the other importins involved in nuclear translocation of corticosteroid-GR complex include importin 7, importin 8, and importin 13 [29, 48, 57, 58]. However, whether the NLS1 sequence, to which these importins bind, is the same or different is not very well understood [55] even though the presence of both NLS1 and NLS2 on GR and its binding to importin-7 has been found in nonmammalian cells, suggesting the crucial role of both NLSs for translocation of GR into nucleus [55]. Importin β stimulates the binding of GR to importin α, whether it is involved in the translocation of GR into the nucleus is poorly defined.

Recently, Hakim and colleagues [58] confirmed earlier findings of Xiao et al. [48] that importin 7 is critical in the translocation of glucocorticoid receptor from the cytoplasm into the nucleus (Figure 4). Also, the expression of the cofactor of importin 7 complex, RanGTP, is reduced during oxidative stress-induced corticosteroid insensitivity, as shown in the presence of hydrogen peroxide [58]. Interestingly, the degree of loss of importin 7 correlates well with the reduction in GR nuclear translocation and insensitivity of corticosteroids [58]. In several cases of severe asthma and chronic obstructive pulmonary disease (COPD), corticosteroids are not very effective [59]. In chronic inflammation, biomarkers of oxidative stress such as oxidant hydrogen peroxide and 8-isoprostane are upregulated, leading to exacerbated inflammation. This uncontrolled oxidative stress results in glucocorticoid insensitivity in the biosystem [60]. The diminished expression of importin 7 can knock down the protective effect of glucocorticoid receptors in human macrophages cell line, which might support the critical role of importin 7 in transporting GR from cytoplasm to the nucleus [58]. However, whether or not the insensitivity of corticosteroids in severe asthmatic and COPD patients is due to the defect in importin 7 is not known and warrants further studies in allergic subjects.

One of the mechanisms of corticosteroid-induced inhibition of Th2 response could be due to the competition between GR and GATA-3 to bind to importin α since both GR and GATA-3 utilize this karyopherin. Maneechotesuwan et al. [60] reported that fluticasone, a synthetic corticosteroid, either under in vitro conditions or upon inhalation causes suppression in nuclear transport of GATA-3 in human T lymphocytes. In this study, the interaction between GR and importin-α was found to be very effective even at low concentration of fluticasone. There was a reduction in GATA-3-importin α complex and an increase in GR-importin-α interactions when fluticasone was inhaled by asthmatic patients [60].

GR can also be carried into the nucleus by importin 7 and importin 13 [55, 58, 59] (Figure 4). Since NF-κB and AP-1 activity can also be inhibited by GR, it is likely that GR has a higher affinity for the karyopherins than the inflammatory transcription factors and/or activated GR induces the production of endogenous inhibitors of importins involved in the translocation of inflammatory transcription factors. Therefore, any defect either in the activation of GR or its translocation into the nucleus could be responsible for the lack of responsiveness or decreased response to corticosteroids. On the other hand, there could be variants of importins that enhance the entry of GR to the nucleus and thus enhance the response to corticosteroids. Indeed, a genetic variant in importin 13 has been found to be associated with improved PC₂₀ (i.e., decreased airway hyperresponsiveness) to methacholine in mild-to-moderate asthmatic children [61]. Accordingly, potential polymorphisms in various importins in allergic subjects could dictate proinflammatory or anti-inflammatory response.

9. Outstanding Questions and Future Directions

Since the nuclear import and export of the proteins occur in highly systematic and organized manner, it is critical to understand the precise regulatory mechanisms of the importin and exportin molecules with respect to their synthesis and function. This would assist in targeting specific sites to allow for the development of better therapeutic approaches in allergic diseases (Figure 5). Since several importin molecules are nonspecific in nature, antagonists or antibodies specifically against a particular importin might not prove to be clinically beneficial. However, additional knowledge regarding the precise control over the recruitment and activation of a few key karyopherins could be beneficial in the development of better therapeutic approaches. In addition, further studies regarding the absence and presence of endogenous mediators that regulate karyopherins in clinical allergic conditions would be informative. Potential polymorphisms and genetic variants in key importin molecules and the epigenetic control of karyopherins are also wide open fields for further investigation (Figure 5). At present, there are no studies on the nucleocytoplasmic shuttling of Foxp3 and T-bet, key transcription factors associated with allergic diseases. Overall, the potential role of importins and exportins in the regulation of allergic immune response is indeed both fascinating and challenging and thus warrants further investigation.

Figure 5: Schematic diagram showing various target sites for intervention in allergic diseases: there are many sites in the importin-exportin system in inflammatory cells involved in allergic diseases. Detailed knowledge on the involvement and role of specific importin molecule and/or the synthesis of mimetics/activators of endogenous inhibitors would help in the development of better therapeutic approaches in allergic diseases.

Disclaimer

The content of this review is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgment

This work was supported by research Grants R01AI075315, R01HL073349, and R01HL116042 from the National Institutes of Health, USA, to D. K. Agrawal. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the paper apart from those disclosed.

References

M. A. Zanta, P. Belguise-Valladier, and J. P. Behr, “Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 1, pp. 91–96, 1999.

I. K. H. Poon and D. A. Jans, “Regulation of nuclear transport: central role in development and transformation?” Traffic, vol. 6, no. 3, pp. 173–186, 2005.

O. J. Gruss, R. E. Carazo-Salas, C. A. Schatz et al., “Ran induces spindle assembly by reversing the inhibitory effect of importin α on TPX2 activity,” Cell, vol. 104, no. 1, pp. 83–93, 2001.

K. Weis, I. W. Mattaj, and A. I. Lamond, “Identification of hSRP1α as a functional receptor for nuclear localization sequences,” Science, vol. 268, no. 5213, pp. 1049–1053, 1995.

M. Köhler, S. Ansieau, S. Prehn, A. Leutz, H. Haller, and E. Hartmann, “Cloning of two novel human importin-α subunits and analysis of the expression pattern of the importin-α protein family,” FEBS Letters, vol. 417, no. 1, pp. 104–108, 1997.

M. Köhler, C. Speck, M. Christiansen et al., “Evidence for distinct substrate specificities of importin α family members in nuclear protein import,” Molecular and Cellular Biology, vol. 19, no. 11, pp. 7782–7791, 1999.

P. Cortes, Z. S. Ye, and D. Baltimore, “RAG-1 interacts with the repeated amino acid motif of the human homologue of the yeast protein SRP1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 16, pp. 7633–7637, 1994.

D. Görlich and U. Kutay, “Transport between the cell nucleus and the cytoplasm,” Annual Review of Cell and Developmental Biology, vol. 15, pp. 607–660, 1999.

M. V. Nachury, U. W. Ryder, A. I. Lamond, and K. Weis, “Cloning and characterization of hSRP1γ, a tissue-specific nuclear transport factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 2, pp. 582–587, 1998.

Y. Miyamoto, N. Imamoto, T. Sekimoto et al., “Differential modes of nuclear localization signal (NLS) recognition by three distinct classes of NLS receptors,” Journal of Biological Chemistry, vol. 272, no. 42, pp. 26375–26381, 1997.

T. Agrawal, G. K. Gupta, and D. K. Agrawal, “Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model,” Clinical & Experimental Allergy, vol. 43, no. 6, pp. 672–683, 2013.

S. Finotto, G. T. de Sanctis, H. A. Lehr et al., “Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression,” Journal of Experimental Medicine, vol. 193, no. 11, pp. 1247–1260, 2001.

Y. Bossé, K. Maghni, and T. J. Hudson, “1α,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes,” Physiological Genomics, vol. 29, no. 2, pp. 161–168, 2007.

R. H. Kehlenbach, A. Dickmanns, and L. Gerace, “Nucleocytoplasmic shuttling factors including Ran and CRM1 mediate nuclear export of NFAT in vitro,” Journal of Cell Biology, vol. 141, no. 4, pp. 863–874, 1998.

G. Lipowsky, F. R. Bischoff, P. Schwarzmaier et al., “Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes,” EMBO Journal, vol. 19, no. 16, pp. 4362–4371, 2000.

I. E. Wertz and V. M. Dixit, “Regulation of death receptor signaling by the ubiquitin system,” Cell Death and Differentiation, vol. 17, no. 1, pp. 14–24, 2010.

Z. Han, D. L. Boyle, A. M. Manning, and G. S. Firestein, “AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis,” Autoimmunity, vol. 28, no. 4, pp. 197–208, 1998.

J. Louten, K. Boniface, and R. de Waal Malefyt, “Development and function of TH17 cells in health and disease,” Journal of Allergy and Clinical Immunology, vol. 123, no. 5, pp. 1004–1011, 2009.

A. A. Lighvani, D. M. Frucht, D. Jankovic et al., “T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 15137–15142, 2001.

I. M. Djuretic, D. Levanon, V. Negreanu, Y. Groner, A. Rao, and K. M. Ansel, “Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells,” Nature Immunology, vol. 8, no. 2, pp. 145–153, 2007.

J. Zhu, L. Guo, C. J. Watson, J. Hu-Li, and W. E. Paul, “Stat6 is necessary and sufficient for IL-4's role in TH2 differentiation and cell expansion,” Journal of Immunology, vol. 166, no. 12, pp. 7276–7281, 2001.

D. K. Agrawal, K. Ariyarathna, and P. W. Kelbe, “(S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells,” Journal of Allergy and Clinical Immunology, vol. 113, no. 3, pp. 503–510, 2004.

M. R. Edwards, N. W. Bartlett, D. Clarke, M. Birrell, M. Belvisi, and S. L. Johnston, “Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease,” Pharmacology & Therapeutics, vol. 121, no. 1, pp. 1–13, 2009.

P. J. Barnes and M. Karin, “Nuclear factor-κB—a pivotal transcription factor in chronic inflammatory diseases,” New England Journal of Medicine, vol. 336, no. 15, pp. 1066–1071, 1997.

R. Fagerlund, L. Kinnunen, M. Köhler, I. Julkunen, and K. Melén, “NF-κB is transported into the nucleus by importin α3 and importin α4,” Journal of Biological Chemistry, vol. 280, no. 16, pp. 15942–15951, 2005.

S. H. Lee and M. Hannink, “The N-terminal nuclear export sequence of IκBα is required for RanGTP-dependent binding to CRM1,” Journal of Biological Chemistry, vol. 276, no. 26, pp. 23599–23606, 2001.

A. L. Theiss, A. K. Jenkins, N. I. Okoro, J. M. A. Klapproth, D. Merlin, and S. V. Sitaraman, “Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin α3 expression,” Molecular Biology of the Cell, vol. 20, no. 20, pp. 4412–4423, 2009.

T. Agrawal, G. K. Gupta, and D. K. Agrawal, “Calcitriol decreases expression of importin α3 and attenuates RelA translocation in human bronchial smooth muscle cells,” Journal of Clinical Immunology, vol. 32, no. 5, pp. 1093–1103, 2012.

M. Zhang, B. Hu, T. Li et al., “A CRM1-dependent nuclear export signal controls nucleocytoplasmic translocation of HSCARG, which regulates NF-κB activity,” Traffic, vol. 13, no. 6, pp. 790–799, 2012.

M. Zerfaoui, Y. Errami, A. S. Naura et al., “Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-κB upon TLR4 stimulation,” Journal of Immunology, vol. 185, no. 3, pp. 1894–1902, 2010.

D. Tang, R. Kang, W. Xiao, H. Wang, S. K. Calderwood, and X. Xiao, “The anti-inflammatory effects of heat shock protein 72 involve inhibition of high-mobility-group box 1 release and proinflammatory function in macrophages,” Journal of Immunology, vol. 179, no. 2, pp. 1236–1244, 2007.

E. Shaulian and M. Karin, “AP-1 in cell proliferation and survival,” Oncogene, vol. 20, no. 19, pp. 2390–2400, 2001.

J. K. Forwood, M. H. C. Lam, and D. A. Jans, “Nuclear import of Creb and AP-1 transcription factors requires importin-β1 and Ran but is independent of importin-α,” Biochemistry, vol. 40, no. 17, pp. 5208–5217, 2001.

C. Yan, L. H. Lee, and L. I. Davis, “Crm1p mediates regulated nuclear export of a yeast AP-1-like transcription factor,” EMBO Journal, vol. 17, no. 24, pp. 7416–7429, 1998.

J. Zhu, H. Yamane, J. Cote-Sierra, L. Guo, and W. E. Paul, “GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors,” Cell Research, vol. 16, no. 1, pp. 3–10, 2006.

M. Yamashita, M. Ukai-Tadenuma, T. Miyamoto et al., “Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci,” Journal of Biological Chemistry, vol. 279, no. 26, pp. 26983–26990, 2004.

K. Maneechotesuwan, Y. Xin, K. Ito et al., “Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3,” Journal of Immunology, vol. 178, no. 4, pp. 2491–2498, 2007.

Z. Yang, L. Gu, P. H. Romeo et al., “Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains,” Molecular and Cellular Biology, vol. 14, no. 3, pp. 2201–2212, 1994.

L. Chialda, M. Zhang, K. Brune, and A. Pahl, “Inhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia,” Respiratory Research, vol. 6, article 36, 2005.

D. C. Underwood, R. R. Osborn, C. J. Kotzer et al., “SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence,” Journal of Pharmacology and Experimental Therapeutics, vol. 293, no. 1, pp. 281–288, 2000.

M. Akdis and C. A. Akdis, “IgE class switching and cellular memory,” Nature Immunology, vol. 13, no. 4, pp. 312–314, 2012.

H. C. Chen and N. C. Reich, “Live cell imaging reveals continuous STAT6 nuclear trafficking,” Journal of Immunology, vol. 185, no. 1, pp. 64–70, 2010.

R. Fagerlund, K. Mélen, L. Kinnunen, and I. Julkunen, “Arginine/lysine-rich nuclear localization signals mediate interactions between dimeric STATs and importin alpha 5,” Journal of Biological Chemistry, vol. 277, no. 33, pp. 30072–30078, 2002.

L. Liu, K. M. McBride, and N. C. Reich, “STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-α3,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 23, pp. 8150–8155, 2005.

J. Ma and X. Cao, “Regulation of Stat3 nuclear import by importin α5 and importin α7 via two different functional sequence elements,” Cellular Signalling, vol. 18, no. 8, pp. 1117–1126, 2006.

B. Rost, G. Yachdav, and J. Liu, “The PredictProtein server,” Nucleic Acids Research, vol. 32, pp. W321–W326, 2004.

Y. Kurebayashi, S. Nagai, A. Ikejiri, et al., “PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORgamma,” Cell Reports, vol. 1, no. 4, pp. 360–373, 2012.

Z. Xiao, X. Liu, Y. I. Henis, and H. F. Lodish, “A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 14, pp. 7853–7858, 2000.

X. Yao, X. Chen, C. Cottonham, and L. Xu, “Preferential utilization of Imp7/8 in nuclear import of Smads,” Journal of Biological Chemistry, vol. 283, no. 33, pp. 22867–22874, 2008.

T. Agrawal, G. K. Gupta, and D. K. Agrawal, “Calcitriol decreases expression of importin α3 and attenuates RelA translocation in human bronchial smooth muscle cells,” Journal of Clinical Immunology, vol. 32, no. 5, pp. 1093–1103, 2012.

T. Agrawal, G. K. Gupta, and D. K. Agrawal, “Vitamin D deficiency decreases the expression of VDR and prohibitin in the lungs of mice with allergic airway inflammation,” Experimental and Molecular Pathology, vol. 93, no. 1, pp. 74–81, 2012.

L. G. J. Nijtmans, L. de Jong, M. A. Sanz et al., “Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins,” EMBO Journal, vol. 19, no. 11, pp. 2444–2451, 2000.

A. L. Theiss, T. S. Obertone, D. Merlin, and S. V. Sitaraman, “Interleukin-6 transcriptionally regulates prohibitin expression in intestinal epithelial cells,” Journal of Biological Chemistry, vol. 282, no. 17, pp. 12804–12812, 2007.

T. Rhen and J. A. Cidlowski, “Antiinflammatory action of glucocorticoids—new mechanisms for old drugs,” New England Journal of Medicine, vol. 353, no. 16, pp. 1711–1658, 2005.

N. D. Freedman and K. R. Yamamoto, “Importin 7 and importin α/importin β are nuclear import receptors for the glucocorticoid receptor,” Molecular Biology of the Cell, vol. 15, no. 5, pp. 2276–2286, 2004.

D. Picard and K. R. Yamamoto, “Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor,” EMBO Journal, vol. 6, no. 11, pp. 3333–3340, 1987.

T. Tao, J. Lan, G. L. Lukacs, R. J. G. Haché, and F. Kaplan, “Importin 13 regulates nuclear import of the glucocorticoid receptor in airway epithelial cells,” The American Journal of Respiratory Cell and Molecular Biology, vol. 35, no. 6, pp. 668–680, 2006.

A. Hakim, P. J. Barnes, I. M. Adcock, and O. S. Usmani, “Importin-7 mediates glucocorticoid receptor nuclear import and is impaired by oxidative stress, leading to glucocorticoid insensitivity,” FASEB Journal, vol. 27, no. 11, pp. 4510–4519, 2013.

S. Suissa and P. J. Barnes, “Inhaled corticosteroids in COPD: the case against,” European Respiratory Journal, vol. 34, no. 1, pp. 13–16, 2009.

K. Maneechotesuwan, X. Yao, K. Ito et al., “Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease,” PLoS Medicine, vol. 6, no. 5, Article ID e1000076, 2009.

B. A. Raby, K. van Steen, J. Lasky-Su, K. Tantisira, F. Kaplan, and S. T. Weiss, “Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma,” Respiratory Research, vol. 10, article 67, 2009.

B. W. Pickard, A. B. Hodsman, L. J. Fraher, and P. H. Watson, “Type 1 parathyroid hormone receptor (PTH1R) nuclear trafficking: association of PTH1R with importin α1 and β,” Endocrinology, vol. 147, no. 7, pp. 3326–3332, 2006.

X. Yao, H. Y. He, Y. Yang et al., “Inhibition of interleukin-13 gene expression in T cells through GATA-3 pathway by arsenic trioxide,” Chinese Medical Journal, vol. 121, no. 22, pp. 2346–2349, 2008.

S. E. Wilkie, K. J. Morris, S. S. Bhattacharya, M. J. Warren, and D. M. Hunt, “A study of the nuclear trafficking of the splicing factor protein PRPF31 linked to autosomal dominant retinitis pigmentosa (ADRP),” Biochimica et Biophysica Acta, vol. 1762, no. 3, pp. 304–311, 2006.

F. Fazal, M. Minhajuddin, K. M. Bijli, J. L. McGrath, and A. Rahman, “Evidence for actin cytoskeleton-dependent and -independent pathways for RelA/p65 nuclear translocation in endothelial cells,” Journal of Biological Chemistry, vol. 282, no. 6, pp. 3940–3950, 2007.

S. Bhushan, C. Kuhn, A. K. Berglund, C. Roth, and E. Glaser, “The role of the N-terminal domain of chloroplast targeting peptides in organellar protein import and miss-sorting,” FEBS Letters, vol. 580, no. 16, pp. 3966–3972, 2006.

A. Argentaro, H. Sim, S. Kelly et al., “A SOX9 defect of calmodulin-dependent nuclear import in campomelic dysplasia/autosomal sex reversal,” Journal of Biological Chemistry, vol. 278, no. 36, pp. 33839–33847, 2003.

J. D. Moore, J. Yang, R. Truant, and S. Kornbluth, “Nuclear import of Cdk/cyclin complexes: identification of distinct mechanisms for import of Cdk2/cyclin E and Cdc2/cyclin B1,” Journal of Cell Biology, vol. 144, no. 2, pp. 213–224, 1999.

K. Ishiguro, T. Ando, O. Maeda, N. Ohmiya, Y. Niwa, and H. Goto, “Acetate inhibits NFAT activation in T cells via importin β1 interference,” European Journal of Immunology, vol. 37, no. 8, pp. 2309–2316, 2007.

L. G. Le Roux and J. Moroianu, “Nuclear entry of high-risk human papillomavirus type 16 E6 oncoprotein occurs via several pathways,” Journal of Virology, vol. 77, no. 4, pp. 2330–2337, 2003.

I. Waldmann, S. Wälde, and R. H. Kehlenbach, “Nuclear import of c-Jun is mediated by multiple transport receptors,” Journal of Biological Chemistry, vol. 282, no. 38, pp. 27685–27692, 2007.

L. F. Pemberton, G. Blobel, and J. S. Rosenblum, “Transport routes through the nuclear pore complex,” Current Opinion in Cell Biology, vol. 10, no. 3, pp. 392–399, 1998.

Y. Miyauchi, T. Michigami, N. Sakaguchi et al., “Importin 4 is responsible for ligand-independent nuclear translocation of vitamin D receptor,” Journal of Biological Chemistry, vol. 280, no. 49, pp. 40901–40908, 2005.

G. Chachami, E. Paraskeva, J. M. Mingot, G. G. Braliou, D. Görlich, and G. Simos, “Transport of hypoxia-inducible factor HIF-1α into the nucleus involves importins 4 and 7,” Biochemical and Biophysical Research Communications, vol. 390, no. 2, pp. 235–240, 2009.

S. Jäkel, W. Albig, U. Kutay et al., “The importin β/importin 7 heterodimer is a functional nuclear import receptor for histone H1,” EMBO Journal, vol. 18, no. 9, pp. 2411–2423, 1999.

L. Xu, C. Alarcón, S. Çöl, and J. Massagué, “Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import,” Journal of Biological Chemistry, vol. 278, no. 43, pp. 42569–42577, 2003.

K. A. Dean, O. Von Ahsen, D. Görlich, and H. M. Fried, “Signal recognition particle protein 19 is imported into the nucleus by importin 8 (RanBP8) and transportin,” Journal of Cell Science, vol. 114, part 19, pp. 3479–3485, 2001.

E. J. Lubert and K. D. Sarge, “Interaction between protein phosphatase 2A and members of the importin β superfamily,” Biochemical and Biophysical Research Communications, vol. 303, no. 3, pp. 908–913, 2003.

S. M. Plafker and I. G. Macara, “Ribosomal protein L12 uses a distinct nuclear import pathway mediated by importin 11,” Molecular and Cellular Biology, vol. 22, no. 4, pp. 1266–1275, 2002.

S. M. Plafker and I. G. Macara, “Importin-11, a nuclear import receptor for the ubiquitin-conjugating enzyme, UbcM2,” EMBO Journal, vol. 19, no. 20, pp. 5502–5513, 2000.

A. C. Hearps and D. A. Jans, “HIV-1 integrase is capable of targeting DNA to the nucleus via an Importin α/β-dependent mechanism,” Biochemical Journal, vol. 398, no. 3, pp. 475–484, 2006.

S. H. Liang and M. F. Clarke, “The nuclear import of p53 is determined by the presence of a basic domain and its relative position to the nuclear localization signal,” Oncogene, vol. 18, no. 12, pp. 2163–2166, 1999.

S. Benzeno and J. A. Diehl, “C-terminal sequences direct cyclin D1-CRM1 binding,” Journal of Biological Chemistry, vol. 279, no. 53, pp. 56061–56066, 2004.

S. H. Lee and M. Hannink, “Characterization of the nuclear import and export functions of IκBε,” Journal of Biological Chemistry, vol. 277, no. 26, pp. 23358–23366, 2002.

P. Macchi, A. M. Brownawell, B. Grunewald, L. DesGroseillers, I. G. Macara, and M. A. Kiebler, “The brain-specific double-stranded RNA-binding protein Staufen2. Nucleolar accumulation and isoform-specific exportin-5-dependent export,” Journal of Biological Chemistry, vol. 279, no. 30, pp. 31440–31444, 2004.

M. T. Bohnsack, T. Stüven, C. Kuhn, V. C. Cordes, and D. Görlich, “A selective block of nuclear actin export stabilizes the giant nuclei of Xenopus oocytes,” Nature Cell Biology, vol. 8, no. 3, pp. 257–263, 2006.

J. M. Mingot, M. T. Bohnsack, U. Jäkle, and D. Görlich, “Exportin 7 defines a novel general nuclear export pathway,” EMBO Journal, vol. 23, no. 16, pp. 3227–3236, 2004.

T. Kuwabara, M. Warashina, M. Sano et al., “Recognition of engineered tRNAs with an extended 3′ end byexportin-t (Xpo-t) and transport of tRNA-attached ribozymes to the cytoplasm in somatic cells,” Biomacromolecules, vol. 2, no. 4, pp. 1229–1242, 2001.